鲍慧铮, 魏小娟. PET指导预后良好的早期霍奇金淋巴瘤的治疗——HD16研究的最终结果[J]. 循证医学, 2020, 20(2): 76-79. DOI: 10.12019/j.issn.1671-5144.2020.02.003
    引用本文: 鲍慧铮, 魏小娟. PET指导预后良好的早期霍奇金淋巴瘤的治疗——HD16研究的最终结果[J]. 循证医学, 2020, 20(2): 76-79. DOI: 10.12019/j.issn.1671-5144.2020.02.003
    BAO Hui-zheng, WEI Xiao-juan. PET-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of HD16 Trial[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 76-79. DOI: 10.12019/j.issn.1671-5144.2020.02.003
    Citation: BAO Hui-zheng, WEI Xiao-juan. PET-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of HD16 Trial[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 76-79. DOI: 10.12019/j.issn.1671-5144.2020.02.003

    PET指导预后良好的早期霍奇金淋巴瘤的治疗——HD16研究的最终结果

    PET-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of HD16 Trial

    /

    返回文章
    返回